Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Sobol

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 31, 1997
Construction and characterization of retroviral vectors for interleukin-2 gene therapyH Fakhrai, D L Shawler, C Van Beveren, et al.
Frontiers in Molecular Biosciences|March 20, 2023
A low-cost recombinant glycoconjugate vaccine confers immunogenicity and protection against enterotoxigenic <i>Escherichia coli</i> infections in miceAsher J Williams, Katherine F Warfel, Primit Desai, et al.
Clinical and Experimental Immunology|July 9, 2002
Antigenic and immunologic characterization of an allogeneic colon carcinoma vaccineD L Shawler, R M Bartholomew, M A Garrett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
Interleukin 2 gene therapy of colorectal carcinoma with autologous irradiated tumor cells and genetically engineered fibroblasts: a Phase I studyR E Sobol, D L Shawler, C Carson, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2024
Development of cell-free platforms for discovering, characterizing, and engineering post-translational modificationsDerek A Wong, Zachary M Shaver, Maria D Cabezas, et al.
American Journal of Medical Genetics. Part A|January 10, 2024
Recurrent missense variant identified in two unrelated families with MPZL2-related hearing loss, expanding the variant spectrum associated with DFNB111Emma Lo, Justin Blair, Nobuko Yamamoto, et al.
Plos One|May 30, 2008
Age of child, more than HPV type, is associated with clinical course in recurrent respiratory papillomatosisFarrel J Buchinsky, Joseph Donfack, Craig S Derkay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
Biomarkers Predict p53 Gene Therapy Efficacy in Recurrent Squamous Cell Carcinoma of the Head and NeckJohn Nemunaitis, Gary Clayman, Sanjiv S Agarwala, et al.
Nature Communications|August 5, 2025
Characterizing and engineering post-translational modifications with high-throughput cell-free expressionDerek A Wong, Zachary M Shaver, Maria D Cabezas, et al.
International Journal of Pediatric Otorhinolaryngology|December 26, 2023
International pediatric otolaryngology group (IPOG) consensus on approach to aspirationBshair Aldriweesh, Ahmed Alkhateeb, An Boudewyns, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 31, 1997
Construction and characterization of retroviral vectors for interleukin-2 gene therapyH Fakhrai, D L Shawler, C Van Beveren, et al.
Frontiers in Molecular Biosciences|March 20, 2023
A low-cost recombinant glycoconjugate vaccine confers immunogenicity and protection against enterotoxigenic <i>Escherichia coli</i> infections in miceAsher J Williams, Katherine F Warfel, Primit Desai, et al.
Clinical and Experimental Immunology|July 9, 2002
Antigenic and immunologic characterization of an allogeneic colon carcinoma vaccineD L Shawler, R M Bartholomew, M A Garrett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
Interleukin 2 gene therapy of colorectal carcinoma with autologous irradiated tumor cells and genetically engineered fibroblasts: a Phase I studyR E Sobol, D L Shawler, C Carson, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2024
Development of cell-free platforms for discovering, characterizing, and engineering post-translational modificationsDerek A Wong, Zachary M Shaver, Maria D Cabezas, et al.
American Journal of Medical Genetics. Part A|January 10, 2024
Recurrent missense variant identified in two unrelated families with MPZL2-related hearing loss, expanding the variant spectrum associated with DFNB111Emma Lo, Justin Blair, Nobuko Yamamoto, et al.
Plos One|May 30, 2008
Age of child, more than HPV type, is associated with clinical course in recurrent respiratory papillomatosisFarrel J Buchinsky, Joseph Donfack, Craig S Derkay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
Biomarkers Predict p53 Gene Therapy Efficacy in Recurrent Squamous Cell Carcinoma of the Head and NeckJohn Nemunaitis, Gary Clayman, Sanjiv S Agarwala, et al.
Nature Communications|August 5, 2025
Characterizing and engineering post-translational modifications with high-throughput cell-free expressionDerek A Wong, Zachary M Shaver, Maria D Cabezas, et al.
International Journal of Pediatric Otorhinolaryngology|December 26, 2023
International pediatric otolaryngology group (IPOG) consensus on approach to aspirationBshair Aldriweesh, Ahmed Alkhateeb, An Boudewyns, et al.
Pageof 11